Back to Search
ANDREA TRAYNOR, MD
MD
Anesthesiology Physician
NPI: 1376531574IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
43604(CO)A72844(CA)
CMS Specialties
PrimaryANESTHESIOLOGY
Education
SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE
Class of 1999
Research & Publications (20)
A dose escalation, safety, and tolerability study of MN-029 in patients with advanced solid tumors.
PMID 19434370·Invest New Drugs·2010
3-trial
A phase II trial of triapine (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503.
PMID 19238328·Invest New Drugs·2010
3-trial
Vorinostat (NSC# 701852) in patients with relapsed non-small cell lung cancer: a Wisconsin Oncology Network phase II study.
PMID 19347984·J Thorac Oncol·2009
3-trial
Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer.
PMID 18701186·Lung Cancer·2009
8-other
Prevalence and reversibility of pulmonary dysfunction in refractory systemic lupus: improvement correlates with disease remission following hematopoietic stem cell transplantation.
PMID 15888846·Chest·2005
8-other
Systemic treatment of advanced non-small cell lung cancer.
PMID 15510241·Drugs Today (Barc)·2004
4-observational
Adjuvant therapy in the treatment of non-small-cell lung cancer.
PMID 14706165·Clin Lung Cancer·2002
8-other
Hematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients.
PMID 12428232·Arthritis Rheum·2002
8-other
Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study.
PMID 11085688·Lancet·2000
3-trial
A pharmacy course on leadership and leading change.
PMID 19513161·Am J Pharm Educ·2009
4-observational
A phase I study of Triapine in combination with doxorubicin in patients with advanced solid tumors.
PMID 19082825·Cancer Chemother Pharmacol·2009
3-trial
Student leadership retreat focusing on a commitment to excellence.
PMID 19564991·Am J Pharm Educ·2009
8-other
Evaluation of mRNA by Q-RTPCR and protein expression by AQUA of the M2 subunit of ribonucleotide reductase (RRM2) in human tumors.
PMID 18941749·Cancer Chemother Pharmacol·2009
4-observational
Dose-escalation study of fixed-dose rate gemcitabine combined with capecitabine in advanced solid malignancies.
PMID 18841362·Cancer Chemother Pharmacol·2009
3-trial
Resolution of SLE-related soft-tissue calcification following haematopoietic stem cell transplantation.
PMID 18326564·Nephrol Dial Transplant·2008
5-case
A phase I pharmacokinetic and pharmacodynamic correlative study of the antisense Bcl-2 oligonucleotide g3139, in combination with carboplatin and paclitaxel, in patients with advanced solid tumors.
PMID 18451239·Clin Cancer Res·2008
3-trial
Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial.
PMID 18640937·J Clin Oncol·2008
3-trial
Phase I/II study of vinorelbine and exisulind as first-line treatment of advanced non-small cell lung cancer in patients at least 70 years old: a wisconsin oncology network study.
PMID 18758305·J Thorac Oncol·2008
3-trial
Dose escalated, hypofractionated radiotherapy using helical tomotherapy for inoperable non-small cell lung cancer: preliminary results of a risk-stratified phase I dose escalation study.
PMID 19044323·Technol Cancer Res Treat·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 300 PASTEUR DR
STANFORD, CA 94305 - Phone
- (650) 723-4000
Quick Facts
- NPI
- 1376531574
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 27
- Publications
- 20
Are you this provider?
Claim Your Profile